Dengue Vaccine Candidate Meets Primary Efficacy Endpoint in Phase 3 Study - Contagionlive.com
Dengue Vaccine Candidate Meets Primary Efficacy Endpoint in Phase 3 Study Contagionlive.com
Takeda Pharmaceutical Company Limited has announced that an investigational dengue vaccine has met the primary efficacy endpoint in an ongoing Phase 3 ...
Comments
Post a Comment